Clean Science & Technology, a midcap player in the specialty chemicals industry, has recently undergone an evaluation adjustment that reflects a shift in its financial metrics. The company’s financial performance for the quarter ending June 2025 has been characterized as flat, leading to a revision in its score. Notably, the Return on Capital Employed (ROCE) for the half-year period stands at 25.18%, which is among the lowest levels observed.
In terms of market performance, Clean Science has faced challenges, with a year-to-date return of -8.81% and a one-year return of -10.05%. This underperformance is evident when compared to the broader market, as the stock has consistently lagged behind the BSE500 index over the past three years.
Despite a modest annual growth rate of 5.88% in operating profit over the last five years, the company’s valuation appears high, with a Price to Book Value ratio of 9.7. The stock is trading at a premium relative to its peers, which may raise concerns among investors.
Overall, the recent evaluation adjustment highlights the ongoing challenges faced by Clean Science & Technology in maintaining a competitive edge in the specialty chemicals sector.
